Clinical trial participation improves survival outcomes by increasing availability of new therapeutic agents in multiple myeloma
Abstract
dose IL-2 skews a glucocorticoid-driven IL-17IL-10 memory CD4 T cell response towards a single IL-10-producing phenotype. J Immunol [Internet]. 2019 Feb 1 [cited 2021 Aug 15];202(3):684–93. https://doi.org/10. 4049/jimmunol.1800697 14. McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, et al. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol [Internet]. 2007 Dec [cited 2021 Aug 08];8(12):1390–7. https:// doi.org/10.1038/ni1539
Read the paper
Related studies
- In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets
- Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery
- Anti-phytopathogenic and plant growth promoting potential of endophytic fungi isolated from Dysoxylum gotadhora
- Mercury toxicity causes iron and sulfur deficiencies along with oxidative injuries in alfalfa (Medicago sativa)
- Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo
- Assessing the Protective Effect of Moringa oleifera Extract against Bone Metastasis: An In Vitro Simulated Digestion Approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.